semaglutide and fatty liver disease targets MASH molecular pathways beyond weight loss Therapeutic Effects of Glucagon-like Peptide-1

Ma, Z., Tanis, J

Hynes highlights concerning findings from animal studies: There was an increased risk of miscarriage and fetal abnormalities, she said while also noting that animal studies do not always correlate with human studies

Why Klinic Chooses Not to Prescribe Ozempic for Weight Loss Despite Ozempic's semaglutide composition, it is specifically approved for type 2 diabetes management

Why Titration Matters More for Retatrutide Than Other GLP-1s In the Phase 2 trial, GI adverse events (primarily nausea, vomiting, and diarrhea) affected 50 to 60 percent of participants at higher doses, according to Jastreboff et al

In addition to quieting that food noise, these types of weight loss medications can actually reduce heart disease, that might be independent of weight loss, in addition to improvements in heart function and functional status in individuals with heart failure. The medication is also currently being studied for how it can target symptoms of kidney disease and Alzheimers

While fat is needed in the diet, it is best to opt for heart-healthy options such as fish, olive oil, nuts, seeds, and avocados (American Heart Association 2025)